dc.contributor.author | Frezza, AM | |
dc.contributor.author | Lee, ATJ | |
dc.contributor.author | Nizri, E | |
dc.contributor.author | Sbaraglia, M | |
dc.contributor.author | Jones, RL | |
dc.contributor.author | Gronchi, A | |
dc.contributor.author | Dei Tos, AP | |
dc.contributor.author | Casali, PG | |
dc.coverage.spatial | England | |
dc.date.accessioned | 2022-09-13T08:57:22Z | |
dc.date.available | 2022-09-13T08:57:22Z | |
dc.date.issued | 2018-05-01 | |
dc.identifier | UNSP e000390 | |
dc.identifier | S2059-7029(20)32309-7 | |
dc.identifier.citation | ESMO Open, 2018, 3 (4), pp. e000390 - | |
dc.identifier.issn | 2059-7029 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/5443 | |
dc.identifier.eissn | 2059-7029 | |
dc.identifier.eissn | 2059-7029 | |
dc.identifier.doi | 10.1136/esmoopen-2018-000390 | |
dc.description.abstract | The 7th edition of the 'ESMO Sarcoma and GIST Symposium' was held in Milan in February 2018. For the first time, the Symposium brought together representatives from the European Reference Network on rare adult solid cancer (EURACAN) joined by sarcoma experts from the USA, Japan and patient advocacy groups, to share insights and discuss future directions in this rare condition. This commentary will summarise the highlights in soft tissue sarcomas. | |
dc.format | Electronic-eCollection | |
dc.format.extent | e000390 - | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER | |
dc.relation.ispartof | ESMO Open | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject | epigenetics | |
dc.subject | euracan | |
dc.subject | immunotherapy | |
dc.subject | massive parallel sequencing | |
dc.subject | soft tissue sarcoma | |
dc.title | 2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2018-05-11 | |
dc.date.updated | 2022-09-13T08:56:30Z | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1136/esmoopen-2018-000390 | |
rioxxterms.licenseref.startdate | 2018-05-01 | |
rioxxterms.type | Journal Article/Review | |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/30018812 | |
pubs.issue | 4 | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones) | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)/Sarcoma Clinical Trials (R Jones) (hon.) | |
pubs.publication-status | Published online | |
pubs.publisher-url | http://dx.doi.org/10.1136/esmoopen-2018-000390 | |
pubs.volume | 3 | |
dc.contributor.icrauthor | Lee, Alexander | |
icr.provenance | Deposited by Mr Arek Surman on 2022-09-13. Deposit type is initial. No. of files: 1. Files: 2018 ESMO Sarcoma and GIST Symposium take-home messages in soft tissue sarcoma.pdf | |